NHS National Framework for Aripiprazole prolonged release injection
ContractHighlights
- Contract period
- —
- Supplier
- Otsuka Pharmaceuticals UK Limited
- Contract value
- —
Details
- Published
- 25 Aug 2026
- Deadline
- —
- Value
- —
- Location
- —
- Source
- Find a Tender
- Source notice ID
- 081037-2026
- OCID
- ocds-h6vhtk-0668bf
- CPV codes
- —
Description
Project title: NHS National Framework for Aripiprazole prolonged release injection commencing 1st February 2027
Offer reference number: CM/TNS/26/5741
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/26/5741 Aripiprazole prolonged release injection
Lot 1 CESW 01/02/2027 to 30/09/2027 (8 months)
Lot 2 NWLN 01/02/2027 to 31/01/2029 (24 months)
Lot 3 LSNE 01/02/2027 to 31/05/2028 (16 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
More from NHS England
View all- Strategic Placement and Education Units for Small ProfessionsPlanningNHS EnglandClosed 14 Sept 2027
- Provision of a Master Vendor Service for Temporary Clinical StaffAwardNHS EnglandAwarded £625,000
- Enabling Flexible Working through e-Rostering Programme: Phase 2 ImplementationAwardNHS EnglandAwarded £166,667
- Sickle Cell and Thalassemia lab clinical support 2027ContractNHS EnglandAwarded
- Enabling Flexible Working through e-Rostering Programme: Phase 2 ImplementationAwardNHS EnglandAwarded £166,667
Lots (1)
| Lot | Title | Value |
|---|---|---|
| 1 | Lot 1 | — |
Awarded contracts (1)
| Title | Supplier | Value | Awarded |
|---|---|---|---|
| Award 1 | Otsuka Pharmaceuticals UK Limited | — | — |